Physician profile
Stuart S Kaplan
NPI 1437126521
$15,967.26
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was more than what 76% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,614 · 2021: $9,552 · 2022: $437 · 2023: $986 · 2024: $2,996 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,398 · Food and Beverage: $1,712 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $252 · Travel and Lodging: $3.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,398.00 |
| Food and Beverage | $1,712.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $252.00 |
| Travel and Lodging | $3.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leica Microsystems INC. | $12,503.32 | 2021-2025 | Hydromark Breast Biopsy Site Marker |
| Hologic INC | $770.19 | 2019-2021 | |
| Hologic Sales and Service, LLC | $737.40 | 2023-2025 | 3dimensions, Trident Specimen Radiography System, Magseed |
| Siemens Medical Solutions USA, INC. | $600.00 | 2019 | |
| Delphinus Medical Technologies, INC. | $482.97 | 2023-2024 | |
| Bard Peripheral Vascular, INC. | $167.99 | 2023 | |
| Elucent Medical | $134.29 | 2023 | |
| Abbvie INC. | $124.97 | 2022 | |
| Amgen INC. | $91.47 | 2019 | |
| Cardinal Health 414 LLC | $90.91 | 2019 | |
| Lunit Americas, INC. | $55.30 | 2019 | |
| Samsung Hme America, INC. | $35.00 | 2024 | |
| Janssen Biotech, INC. | $34.23 | 2019 | |
| Integra Lifesciences Corporation | $33.61 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $22.46 | 2019 | |
| Rigel Pharmaceuticals, INC. | $18.75 | 2019 | |
| Merck Sharp & Dohme LLC | $18.65 | 2019 | |
| Dompe US, INC. | $15.64 | 2024 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.